GARCHING / MUNICH, Germany and SYDNEY, May 19, 2025 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX ...

As part of the agreement, ITM will support H2 Hauler in their development of hydrogen production projects based on our market-leading NEPTUNE V containerised electrolyser technology. These ...

Investing.com -- Shares of ITM Power PLC (LSE:ITM) leaped 14.2% following the announcement that the company has secured a contract to supply over 300MW of electrolyser equipment for a significant ...

ITM Power shares jumped by almost a fifth on Tuesday after the green hydrogen firm lifted annual revenue guidance. The AIM listed group told shareholders 'additional contractual obligations' had ...

ITM Power said it expects annual revenue of between £25.5m and £26.5m, a 30 per cent increase on its prior forecast of £18m and £22m. Shares in ITM Power soared on Tuesday after the green ...

Sheffield-based electrolyser manufacture ITM Power upgraded its revenue forecast by 30% today after fulfilling additional contract obligations. Revenue for FY25 is now expected to be between £25 ...

(Sharecast News) - ITM Power announced on Thursday that it has been chosen by EDF Renewables UK and Hynamics, a subsidiary of EDF Group, to deliver an engineering integration package for phase one ...

In trading on Wednesday, shares of the Intermediate Muni ETF (Symbol: ITM) entered into oversold territory, changing hands as low as $45.33 per share. We define oversold territory using the ...

Every investor in ITM Power Plc (LON:ITM) should be aware of the most powerful shareholder groups. With 47% stake, institutions possess the maximum shares in the company. In other words ...

Every investor in ITM Power Plc (LON:ITM) should be aware of the most powerful shareholder groups. With 47% stake, institutions possess the maximum shares in the company. In other words, the group ...

Kuwait International Bank (KIB) announced the conclusion of its silver sponsorship of the 4th edition of the Kuwait Sustainability Event (KSE), reaffirming its commitment to sustainability ...

But when it came to the secondary endpoint of interim overall survival (OS), the ITM-11 cohort reached 63.4 months while the everolimus group was not far behind at 58.7 months. This gap was ...